States Receive Green Light, Resume Economic ActivitiesBy Miriam Bello | Thu, 06/10/2021 - 12:28
This week marked the historic approval of the first treatment for Alzheimer’s disease that aims to treat the disease’s cause instead of its symptoms. Alongside innovative drug solutions, the world calls for innovation on workspaces and vaccination processes to accelerate a reopening.
Here is the week in health!
A Hopeful Treatment
The FDA approved on Monday the use of aducanumab for the early stages of Alzheimer's. It is the first to be approved against the disease in 20 years.
Mental Health in the Workplace
The pandemic’s shift on working modalities brought high levels of anxiety, burn out and stress to employees. Balancing social life and work on the same space has been a challenge and companies need to meet it head on. During yesterday’s webinar hosted by MBN, HR leaders discussed strategies to cater to their collaborator’s mental health during the “new normal.”
The End of an Era
After over a year of hosting daily COVID-19-track press conferences, Deputy Minister of Health Hugo López-Gatell announced the end of such dynamic. López-Gatell said that the Ministry of Health will now rely on other communication methods such as informative videos, individual press conferences and eventual interviews, to informing on the COVID-19 pandemic in Mexico.
Mexico Welcomes J&J Vaccines
Mexico is to receive 1 million doses of Johnson & Johnson’s single-shot vaccine next week as a donation from the US. The northern country has a large number of unused doses that are soon to expire. Mexico will use this vaccine for adults living in its northern border.
CLIMSS created a vaccination course that aims to help companies perform future massive vaccination campaigns. This program is for those “conducive to installing temporary vaccination centers in companies or through solidarity allies,” which contribute to the reduction of COVID-19 cases and its subsequent mortality.
States Join the “Green Light”
Mexico City and the State of Mexico are now labeled “green” in the country’s traffic light system, indicating that COVID-19 contagion and hospitalization cases have reduced enough to begin reactivating economic activities. State authorities stress that this measure does not mean a stop of safety precautions. On the contrary, authorities are highlighting that facemasks and social distancing practices should be used now more than ever.
Travel Measures Relax
The US relaxed travel restrictions for travelers going to Mexico. The level went from “Level 4: Do not travel” to “Level 3: Reconsider.”
Sanofi’s Vaccines Advance
Last week, Sanofi announced Mexico will be part of the clinical trials for the COVID-19 vaccine it developed with GSK. Fernando Sampaio, Country Lead and General Manager of Sanofi Mexico and Sanofi Pasteur, told MBN that the company is also registering its quadrivalent vaccine that will protect Mexicans from four strains of influenza. The latter vaccine will be available by 2022.
US to donate 500 million Pfizer vaccines
President of the US Joe Biden announced the donation of 500 million COVID-19 doses from Pfizer/BioNTech to at least 92 developing countries.